United States Chitosan Derivatives Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Chitosan Derivatives Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Chitosan Derivatives Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Chitosan Derivatives Overall Market Size
2.1 United States Chitosan Derivatives Market Size: 2021 VS 2027
2.2 United States Chitosan Derivatives Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Chitosan Derivatives Sales: 2016-2027
3 Company Landscape
3.1 Top Chitosan Derivatives Players in United States Market
3.2 Top United States Chitosan Derivatives Companies Ranked by Revenue
3.3 United States Chitosan Derivatives Revenue by Companies
3.4 United States Chitosan Derivatives Sales by Companies
3.5 United States Chitosan Derivatives Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Chitosan Derivatives Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Chitosan Derivatives Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chitosan Derivatives Players in United States Market
3.8.1 List of Tier 1 Chitosan Derivatives Companies in United States
3.8.2 List of Tier 2 and Tier 3 Chitosan Derivatives Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Chitosan Derivatives Market Size Markets, 2021 & 2027
4.1.2 Chitosan HCl
4.1.3 Carboxymethyl Chitosan
4.1.4 Chitosan Quaternary Ammonium Salt
4.1.5 Hydroxypropyl Chitosan
4.1.6 Chitosan Oligosaccharide
4.1.7 Others
4.2 By Type - United States Chitosan Derivatives Revenue & Forecasts
4.2.1 By Type - United States Chitosan Derivatives Revenue, 2016-2021
4.2.2 By Type - United States Chitosan Derivatives Revenue, 2022-2027
4.2.3 By Type - United States Chitosan Derivatives Revenue Market Share, 2016-2027
4.3 By Type - United States Chitosan Derivatives Sales & Forecasts
4.3.1 By Type - United States Chitosan Derivatives Sales, 2016-2021
4.3.2 By Type - United States Chitosan Derivatives Sales, 2022-2027
4.3.3 By Type - United States Chitosan Derivatives Sales Market Share, 2016-2027
4.4 By Type - United States Chitosan Derivatives Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Chitosan Derivatives Market Size, 2021 & 2027
5.1.2 Medical
5.1.3 Health Food
5.1.4 Cosmetics
5.1.5 Water Treatment
5.1.6 Others
5.2 By Application - United States Chitosan Derivatives Revenue & Forecasts
5.2.1 By Application - United States Chitosan Derivatives Revenue, 2016-2021
5.2.2 By Application - United States Chitosan Derivatives Revenue, 2022-2027
5.2.3 By Application - United States Chitosan Derivatives Revenue Market Share, 2016-2027
5.3 By Application - United States Chitosan Derivatives Sales & Forecasts
5.3.1 By Application - United States Chitosan Derivatives Sales, 2016-2021
5.3.2 By Application - United States Chitosan Derivatives Sales, 2022-2027
5.3.3 By Application - United States Chitosan Derivatives Sales Market Share, 2016-2027
5.4 By Application - United States Chitosan Derivatives Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 FMC Corp
6.1.1 FMC Corp Corporation Information
6.1.2 FMC Corp Overview
6.1.3 FMC Corp Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.1.4 FMC Corp Chitosan Derivatives Product Description
6.1.5 FMC Corp Recent Developments
6.2 Kitozyme
6.2.1 Kitozyme Corporation Information
6.2.2 Kitozyme Overview
6.2.3 Kitozyme Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.2.4 Kitozyme Chitosan Derivatives Product Description
6.2.5 Kitozyme Recent Developments
6.3 Kunpoong Bio
6.3.1 Kunpoong Bio Corporation Information
6.3.2 Kunpoong Bio Overview
6.3.3 Kunpoong Bio Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.3.4 Kunpoong Bio Chitosan Derivatives Product Description
6.3.5 Kunpoong Bio Recent Developments
6.4 BIO21
6.4.1 BIO21 Corporation Information
6.4.2 BIO21 Overview
6.4.3 BIO21 Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.4.4 BIO21 Chitosan Derivatives Product Description
6.4.5 BIO21 Recent Developments
6.5 Heppe Medical Chitosan
6.5.1 Heppe Medical Chitosan Corporation Information
6.5.2 Heppe Medical Chitosan Overview
6.5.3 Heppe Medical Chitosan Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.5.4 Heppe Medical Chitosan Chitosan Derivatives Product Description
6.5.5 Heppe Medical Chitosan Recent Developments
6.6 Yaizu Suisankagaku
6.6.1 Yaizu Suisankagaku Corporation Information
6.6.2 Yaizu Suisankagaku Overview
6.6.3 Yaizu Suisankagaku Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.6.4 Yaizu Suisankagaku Chitosan Derivatives Product Description
6.6.5 Yaizu Suisankagaku Recent Developments
6.7 Golden-Shell
6.7.1 Golden-Shell Corporation Information
6.7.2 Golden-Shell Overview
6.7.3 Golden-Shell Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.7.4 Golden-Shell Chitosan Derivatives Product Description
6.7.5 Golden-Shell Recent Developments
6.8 Lushen Bioengineering
6.8.1 Lushen Bioengineering Corporation Information
6.8.2 Lushen Bioengineering Overview
6.8.3 Lushen Bioengineering Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.8.4 Lushen Bioengineering Chitosan Derivatives Product Description
6.8.5 Lushen Bioengineering Recent Developments
6.9 AK BIOTECH
6.9.1 AK BIOTECH Corporation Information
6.9.2 AK BIOTECH Overview
6.9.3 AK BIOTECH Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.9.4 AK BIOTECH Chitosan Derivatives Product Description
6.9.5 AK BIOTECH Recent Developments
6.10 Zhejiang New Fuda Ocean Biotech
6.10.1 Zhejiang New Fuda Ocean Biotech Corporation Information
6.10.2 Zhejiang New Fuda Ocean Biotech Overview
6.10.3 Zhejiang New Fuda Ocean Biotech Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.10.4 Zhejiang New Fuda Ocean Biotech Chitosan Derivatives Product Description
6.10.5 Zhejiang New Fuda Ocean Biotech Recent Developments
6.11 Weifang Sea Source Biological Products
6.11.1 Weifang Sea Source Biological Products Corporation Information
6.11.2 Weifang Sea Source Biological Products Overview
6.11.3 Weifang Sea Source Biological Products Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.11.4 Weifang Sea Source Biological Products Chitosan Derivatives Product Description
6.11.5 Weifang Sea Source Biological Products Recent Developments
6.12 Qingdao Honghai Bio-tech
6.12.1 Qingdao Honghai Bio-tech Corporation Information
6.12.2 Qingdao Honghai Bio-tech Overview
6.12.3 Qingdao Honghai Bio-tech Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.12.4 Qingdao Honghai Bio-tech Chitosan Derivatives Product Description
6.12.5 Qingdao Honghai Bio-tech Recent Developments
6.13 Haidebei Marine Bioengineering
6.13.1 Haidebei Marine Bioengineering Corporation Information
6.13.2 Haidebei Marine Bioengineering Overview
6.13.3 Haidebei Marine Bioengineering Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.13.4 Haidebei Marine Bioengineering Chitosan Derivatives Product Description
6.13.5 Haidebei Marine Bioengineering Recent Developments
6.14 Jiangsu Aoxin Biotechnology
6.14.1 Jiangsu Aoxin Biotechnology Corporation Information
6.14.2 Jiangsu Aoxin Biotechnology Overview
6.14.3 Jiangsu Aoxin Biotechnology Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.14.4 Jiangsu Aoxin Biotechnology Chitosan Derivatives Product Description
6.14.5 Jiangsu Aoxin Biotechnology Recent Developments
6.15 Jinhu Crust Product
6.15.1 Jinhu Crust Product Corporation Information
6.15.2 Jinhu Crust Product Overview
6.15.3 Jinhu Crust Product Chitosan Derivatives Sales and Revenue in United States Market (2016-2021)
6.15.4 Jinhu Crust Product Chitosan Derivatives Product Description
6.15.5 Jinhu Crust Product Recent Developments
7 United States Chitosan Derivatives Production Capacity, Analysis
7.1 United States Chitosan Derivatives Production Capacity, 2016-2027
7.2 Chitosan Derivatives Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Chitosan Derivatives Supply Chain Analysis
9.1 Chitosan Derivatives Industry Value Chain
9.2 Chitosan Derivatives Upstream Market
9.3 Chitosan Derivatives Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Chitosan Derivatives Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Chitosan Derivatives in United States Market
Table 2. Top Chitosan Derivatives Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Chitosan Derivatives Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Chitosan Derivatives Revenue Share by Companies, 2016-2021
Table 5. United States Chitosan Derivatives Sales by Companies, (MT), 2016-2021
Table 6. United States Chitosan Derivatives Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Chitosan Derivatives Price (2016-2021) & (US$/MT)
Table 8. Manufacturers Chitosan Derivatives Product Type
Table 9. List of Tier 1 Chitosan Derivatives Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Chitosan Derivatives Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Chitosan HCl
Table 12. Major Manufacturers of Carboxymethyl Chitosan
Table 13. By Type - United States Chitosan Derivatives Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Chitosan Derivatives Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Chitosan Derivatives Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Chitosan Derivatives Sales (MT), 2016-2021
Table 17. By Type - United States Chitosan Derivatives Sales (MT), 2022-2027
Table 18. By Application - United States Chitosan Derivatives Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Chitosan Derivatives Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Chitosan Derivatives Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Chitosan Derivatives Sales (MT), 2016-2021
Table 22. By Application - United States Chitosan Derivatives Sales (MT), 2022-2027
Table 23. FMC Corp Corporation Information
Table 24. FMC Corp Description and Major Businesses
Table 25. FMC Corp Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 26. FMC Corp Chitosan Derivatives Product
Table 27. FMC Corp Recent Developments
Table 28. Kitozyme Corporation Information
Table 29. Kitozyme Description and Major Businesses
Table 30. Kitozyme Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 31. Kitozyme Chitosan Derivatives Product
Table 32. Kitozyme Recent Developments
Table 33. Kunpoong Bio Corporation Information
Table 34. Kunpoong Bio Description and Major Businesses
Table 35. Kunpoong Bio Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 36. Kunpoong Bio Chitosan Derivatives Product
Table 37. Kunpoong Bio Recent Developments
Table 38. BIO21 Corporation Information
Table 39. BIO21 Description and Major Businesses
Table 40. BIO21 Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 41. BIO21 Chitosan Derivatives Product
Table 42. BIO21 Recent Developments
Table 43. Heppe Medical Chitosan Corporation Information
Table 44. Heppe Medical Chitosan Description and Major Businesses
Table 45. Heppe Medical Chitosan Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 46. Heppe Medical Chitosan Chitosan Derivatives Product
Table 47. Heppe Medical Chitosan Recent Developments
Table 48. Yaizu Suisankagaku Corporation Information
Table 49. Yaizu Suisankagaku Description and Major Businesses
Table 50. Yaizu Suisankagaku Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 51. Yaizu Suisankagaku Chitosan Derivatives Product
Table 52. Yaizu Suisankagaku Recent Developments
Table 53. Golden-Shell Corporation Information
Table 54. Golden-Shell Description and Major Businesses
Table 55. Golden-Shell Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 56. Golden-Shell Chitosan Derivatives Product
Table 57. Golden-Shell Recent Developments
Table 58. Lushen Bioengineering Corporation Information
Table 59. Lushen Bioengineering Description and Major Businesses
Table 60. Lushen Bioengineering Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 61. Lushen Bioengineering Chitosan Derivatives Product
Table 62. Lushen Bioengineering Recent Developments
Table 63. AK BIOTECH Corporation Information
Table 64. AK BIOTECH Description and Major Businesses
Table 65. AK BIOTECH Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 66. AK BIOTECH Chitosan Derivatives Product
Table 67. AK BIOTECH Recent Developments
Table 68. Zhejiang New Fuda Ocean Biotech Corporation Information
Table 69. Zhejiang New Fuda Ocean Biotech Description and Major Businesses
Table 70. Zhejiang New Fuda Ocean Biotech Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 71. Zhejiang New Fuda Ocean Biotech Chitosan Derivatives Product
Table 72. Zhejiang New Fuda Ocean Biotech Recent Developments
Table 73. Weifang Sea Source Biological Products Corporation Information
Table 74. Weifang Sea Source Biological Products Description and Major Businesses
Table 75. Weifang Sea Source Biological Products Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 76. Weifang Sea Source Biological Products Chitosan Derivatives Product
Table 77. Weifang Sea Source Biological Products Recent Developments
Table 78. Qingdao Honghai Bio-tech Corporation Information
Table 79. Qingdao Honghai Bio-tech Description and Major Businesses
Table 80. Qingdao Honghai Bio-tech Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 81. Qingdao Honghai Bio-tech Chitosan Derivatives Product
Table 82. Qingdao Honghai Bio-tech Recent Developments
Table 83. Haidebei Marine Bioengineering Corporation Information
Table 84. Haidebei Marine Bioengineering Description and Major Businesses
Table 85. Haidebei Marine Bioengineering Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 86. Haidebei Marine Bioengineering Chitosan Derivatives Product
Table 87. Haidebei Marine Bioengineering Recent Developments
Table 88. Jiangsu Aoxin Biotechnology Corporation Information
Table 89. Jiangsu Aoxin Biotechnology Description and Major Businesses
Table 90. Jiangsu Aoxin Biotechnology Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 91. Jiangsu Aoxin Biotechnology Chitosan Derivatives Product
Table 92. Jiangsu Aoxin Biotechnology Recent Developments
Table 93. Jinhu Crust Product Corporation Information
Table 94. Jinhu Crust Product Description and Major Businesses
Table 95. Jinhu Crust Product Chitosan Derivatives Sales (MT), Revenue (US$, Mn) and Gross Margin (US$/MT) (2016-2021)
Table 96. Jinhu Crust Product Chitosan Derivatives Product
Table 97. Jinhu Crust Product Recent Developments
Table 98. Chitosan Derivatives Production Capacity (MT) of Key Manufacturers in United States Market, 2019-2021 (MT)
Table 99. United States Chitosan Derivatives Capacity Market Share of Key Manufacturers, 2019-2021
Table 100. Chitosan Derivatives Market Opportunities & Trends in United States Market
Table 101. Chitosan Derivatives Market Drivers in United States Market
Table 102. Chitosan Derivatives Market Restraints in United States Market
Table 103. Chitosan Derivatives Raw Materials
Table 104. Chitosan Derivatives Raw Materials Suppliers in United States Market
Table 105. Typical Chitosan Derivatives Downstream
Table 106. Chitosan Derivatives Downstream Clients in United States Market
Table 107. Chitosan Derivatives Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Chitosan Derivatives Product Picture
Figure 2. Chitosan Derivatives Segment by Type
Figure 3. Chitosan Derivatives Segment by Application
Figure 4. United States Chitosan Derivatives Market Overview: 2020
Figure 5. United States Chitosan Derivatives Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Chitosan Derivatives Revenue, 2016-2027 (US$, Mn)
Figure 7. Chitosan Derivatives Sales in United States Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Chitosan Derivatives Revenue in 2020
Figure 9. Chitosan HCl Product Picture
Figure 10. Carboxymethyl Chitosan Product Picture
Figure 11. Chitosan Quaternary Ammonium Salt Product Picture
Figure 12. Hydroxypropyl Chitosan Product Picture
Figure 13. Chitosan Oligosaccharide Product Picture
Figure 14. By Type - United States Chitosan Derivatives Sales Market Share, 2016-2027
Figure 15. By Type - United States Chitosan Derivatives Revenue Market Share, 2016-2027
Figure 16. By Type - United States Chitosan Derivatives Price (US$/MT), 2016-2027
Figure 17. Medical
Figure 18. Health Food
Figure 19. Cosmetics
Figure 20. Water Treatment
Figure 21. Others
Figure 22. By Application - United States Chitosan Derivatives Sales Market Share, 2016-2027
Figure 23. By Application - United States Chitosan Derivatives Revenue Market Share, 2016-2027
Figure 24. By Application - United States Chitosan Derivatives Price (US$/MT), 2016-2027
Figure 25. FMC Corp Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Kitozyme Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Kunpoong Bio Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. BIO21 Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Heppe Medical Chitosan Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Yaizu Suisankagaku Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Golden-Shell Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Lushen Bioengineering Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. AK BIOTECH Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Zhejiang New Fuda Ocean Biotech Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Weifang Sea Source Biological Products Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Qingdao Honghai Bio-tech Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Haidebei Marine Bioengineering Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Jiangsu Aoxin Biotechnology Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Jinhu Crust Product Chitosan Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. United States Chitosan Derivatives Production Capacity (MT), 2016-2027
Figure 41. Chitosan Derivatives Industry Value Chain
Figure 42. Marketing Channels